Skip to main content
. 2017 Mar 7;17:197. doi: 10.1186/s12879-017-2298-8

Table 1.

Antimicrobial agents and MIC breakpoints for rapidly growing mycobacteria

Antimicrobial agents MICa (μg/mL) for category
Susceptible Intermediate Resistant
Amikacin ≤16 32 ≥64
Tobramycin ≤2 4 ≥8
Tigecycline ≤4 >4
Minocycline ≤1 2–4 ≥8
Ciprofloxacin ≤1 2 ≥4
Moxifloxacin ≤1 2 ≥4
Clarithromycin ≤2 4 ≥8
Linezolid ≤8 16 ≥32
Imipenem ≤4 8–16 ≥32
Meropenem ≤4 8–16 ≥32
Sulfamethoxazole ≤38 ≥76

Abbreviation MIC minimal inhibitory concentration

aBreakpoints of each drug, except for tigecycline, are based on the Clinical and Laboratory Standards Institute recommendations. Breakpoints for tigecycline were based on those proposed by Petrini [17]